Clinical evaluation of a synthetic low molecular weight polymer for advanced gastrointestinal cancer.
D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008970:Molecular Weight; D011108:Polymers / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011108:Polymers; C022084:carboxyimamidate